Sign up UNITED KINGDOM
Proactive Investors - Run By Investors For Investors

GW Pharmaceuticals RNS Release

Director/PDMR Shareholding

RNS Number : 4431N
GW Pharmaceuticals PLC
25 October 2016
 

Notification and public disclosure of transactions by persons discharging

managerial responsibilities and persons closely associated with them 

1.         

Details of the person discharging managerial responsibilities / person closely associated

a.         

Name

Mr Julian Gangolli

2.         

Reason for the notification

a.         

Position/status

Director/President, US

b.         

Initial notification

/Amendment

Initial notification

3.         

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a.         

Name

GW Pharmaceuticals PLC

b.         

LEI

 

4.         

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a.         

Description of the

Financial instrument, type of instrument

Identification code

 

Ordinary shares of 0.1p each

ISIN: GB0030544687

b.         

Nature of the transaction

Exercise of share options to acquire ordinary shares.

 

c.         

Price(s) and volume(s)

 

Price(s)

 0.1p

Volume(s)

10,608

 

Ordinary shares acquired pursuant to option exercise

d.         

Aggregated information

·Aggregated volume

·Price

 

 

n/a

e.         

Date of the transaction

24 October 2016

f.         

Place of the transaction

 London

 

4.         

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a.         

Description of the

Financial instrument, type of instrument

Identification code

Ordinary shares of 0.1p each and American Depositary Shares

 Ordinary Shares: ISIN: GB0030544687

American Depositary shares: ISIN: US36197T1034

b.         

Nature of the transaction

Conversion of Ordinary shares into American Depositary Shares (12 to 1 conversion ratio)

c.         

Price(s) and volume(s)

 

Price(s)

 -

Volume(s)

301

 

ADS's issued upon conversion of 3,612 Ordinary shares

d.         

Aggregated information

·Aggregated volume

·Price

  

n/a

e.         

Date of the transaction

24 October 2016

f.         

Place of the transaction

New York

4.         

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a.         

Description of the

Financial instrument, type of instrument

Identification code

 

 

American Depositary Shares

ISIN: 36197T1034

b.         

Nature of the transaction

Sale of American Depositary shares

c.         

Price(s) and volume(s)

 

Price(s)

 $120.75

Volume(s)

301

 

ADS's sold

d.         

Aggregated information

·Aggregated volume

·Price

 

 

n/a

e.         

Date of the transaction

24 October 2016

f.         

Place of the transaction

Nasdaq, New York

4.         

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a.         

Description of the

Financial instrument, type of instrument

Identification code

Ordinary Share and Restricted American Depositary Shares

Ordinary Shares: ISIN: GB0030544687

Restricted American Depositary shares: ISIN: US36197T1372

b.         

Nature of the transaction

Conversion of Ordinary Shares into Restricted American Depositary shares (12 to 1 Conversion ratio)

c.         

Price(s) and volume(s)

 

Price(s)

 -

Volume(s)

583

Restricted ADSs issued upon conversion of 6,996 Ordinary Shares

d.         

Aggregated information

·Aggregated volume

·Price

 

n/a

e.         

Date of the transaction

24 October 2016

f.         

Place of the transaction

Nasdaq, New York

 

1.         

Details of the person discharging managerial responsibilities / person closely associated

a.         

Name

Mr Christopher Tovey

2.         

Reason for the notification

a.         

Position/status

Director/Chief Operations Officer

b.         

Initial notification

/Amendment

Initial notification

3.         

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a.         

Name

GW Pharmaceuticals PLC

b.         

LEI

 

4.         

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a.         

Description of the

Financial instrument, type of instrument

Identification code

Ordinary shares of 0.1p each

ISIN: GB0030544687

b.         

Nature of the transaction

Exercise of share options to acquire ordinary shares.

c.         

Price(s) and volume(s)

 

Price(s)

 0.1p

Volume(s)

266,557

 

Ordinary shares acquired pursuant to option exercise

d.         

Aggregated information

·Aggregated volume

·Price

 

 

n/a

e.         

Date of the transaction

24 October 2016

f.         

Place of the transaction

 London

4.         

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a.         

Description of the

Financial instrument, type of instrument

Identification code

Ordinary shares of 0.1p each and American Depositary Shares

 Ordinary Shares: ISIN: GB0030544687

American Depositary shares: ISIN: US36197T1034

b.         

Nature of the transaction

Conversion of Ordinary shares into American Depositary Shares (12 to 1 conversion ratio)

c.         

Price(s) and volume(s)

 

Price(s)

 -

Volume(s)

22,213

ADS's issued upon conversion of 266,556 Ordinary shares

d.         

Aggregated information

·Aggregated volume

·Price

 

 

n/a

e.         

Date of the transaction

24 October 2016

f.         

Place of the transaction

New York

4.         

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a.         

Description of the

Financial instrument, type of instrument

Identification code

American Depositary Shares

ISIN: US36197T1034

b.         

Nature of the transaction

Sale of American Depositary shares

c.         

Price(s) and volume(s)

 

Price(s)

 $120.36

Volume(s)

22,213

 

ADS's sold

d.         

Aggregated information

·Aggregated volume

·Price

 

 

n/a

e.         

Date of the transaction

24 October 2016

f.         

Place of the transaction

Nasdaq, New York 

 

1.         

Details of the person discharging managerial responsibilities / person closely associated

a.         

Name

Dr Geoffrey Guy

2.         

Reason for the notification

a.         

Position/status

Director/Chairman of the Board

b.         

Initial notification

/Amendment

Initial notification

3.         

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a.         

Name

GW Pharmaceuticals PLC

b.         

LEI

 

4.         

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a.         

Description of the

Financial instrument, type of instrument

Identification code

Ordinary shares of 0.1p each

ISIN: GB0030544687

b.         

Nature of the transaction

Sale of Ordinary Shares

c.         

Price(s) and volume(s)

 

Price(s)

 £8.43p

Volume(s)

206,100

 

Ordinary shares sold

d.         

Aggregated information

·Aggregated volume

·Price

 

 

n/a

e.         

Date of the transaction

21 October 2016

f.         

Place of the transaction

 AIM, London

4.         

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a.         

Description of the

Financial instrument, type of instrument

Identification code

Ordinary shares of 0.1p each

 Ordinary Shares: ISIN: GB0030544687

b.         

Nature of the transaction

Sale of Ordinary shares

c.         

Price(s) and volume(s)

 

Price(s)

 £8.24

Volume(s)

68,900

 

Ordinary shares sold

d.         

Aggregated information

·Aggregated volume

·Price

 

 

n/a

e.         

Date of the transaction

24 October 2016

f.         

Place of the transaction

AIM, London

 

4.         

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a.         

Description of the

Financial instrument, type of instrument

Identification code

0.1  Pence Ordinary Shares

ISIN:GB0030544687

b.         

Nature of the transaction

Sale of Ordinary shares

c.         

Price(s) and volume(s)

 

Price(s)

 £8.09

Volume(s)

125,000

 

Ordinary Shares sold

d.         

Aggregated information

·Aggregated volume

·Price

 

 

n/a

e.         

Date of the transaction

25 October 2016

f.         

Place of the transaction

AIM, London

 

1.         

Details of the person discharging managerial responsibilities / person closely associated

a.         

Name

Dr Stephen Wright

2.         

Reason for the notification

a.         

Position/status

Director/Chief Medical Officer

b.         

Initial notification

/Amendment

Initial notification

3.         

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a.         

Name

GW Pharmaceuticals PLC

b.         

LEI

 

4.         

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a.         

Description of the

Financial instrument, type of instrument

Identification code

Ordinary shares of 0.1p each

ISIN: GB0030544687

b.         

Nature of the transaction

Sale of Ordinary Shares by the wife of Dr Stephen Wright

c.         

Price(s) and volume(s)

 

Price(s)

 £8.10p

Volume(s)

1,556

 

Ordinary shares sold

d.         

Aggregated information

·Aggregated volume

·Price

 

 

n/a

e.         

Date of the transaction

25 October 2016

f.         

Place of the transaction

 AIM, London

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHLLFSRIILEFIR



GW Pharmaceuticals Timeline

© Proactive Investors 2017

Proactive Investor UK Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use